Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Natco Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524816NSE Symbol: NATCOPHARMP/E(TTM):14.77
ISIN Demat:INE987B01026Div & Yield %:0.56EPS(TTM):67.65
Book Value(Rs):284.4746621Market Cap ( Cr.):17899.34Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 2351.001767.801653.501790.201986.302108.50
Excise Duty0.000.000.000.000.0017.20
Net Sales2351.001767.801653.501790.201986.302091.30
Other Income 85.5094.60101.10123.80129.8039.40
Stock Adjustments -34.605.5046.9055.9025.5024.70
Total Income2401.901867.901801.501969.902141.602155.40
EXPENDITURE :      
Raw Materials 495.10540.10546.90452.90364.60413.20
Power & Fuel Cost81.9076.4059.4062.4059.6056.10
Employee Cost 425.70410.10380.00356.10340.20312.20
Other Manufacturing Expenses 150.30148.70114.30134.70119.70120.20
Selling and Administration Expenses 290.70309.10140.30202.30253.70248.90
Miscellaneous Expenses 28.0075.9041.9059.7057.5037.00
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1471.701560.301282.801268.101195.301187.60
Operating Profit930.20307.60518.70701.80946.30967.80
Interest 8.6013.3011.3020.6018.8014.70
Gross Profit921.60294.30507.40681.20927.50953.10
Depreciation150.90138.40115.2098.1080.1065.50
Profit Before Tax770.70155.90392.20583.10847.40887.60
Tax133.1032.5093.30129.10186.30217.30
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.50-15.70-10.60-20.50-6.00-27.90
Reported Net Profit637.10139.10309.50474.50667.10698.20
Extraordinary Items 14.7133.8024.3912.6910.537.78
Adjusted Net Profit622.39105.30285.11461.81656.57690.42
Adjst. below Net Profit -1.000.402.20-31.40-27.40-30.80
P & L Balance brought forward2587.102520.502322.502006.801459.00954.40
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 88.6072.90113.90127.4091.90150.90
P & L Balance carried down3134.602587.102520.302322.502006.801470.90
Dividend100.4082.10113.90127.4091.90150.90
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %275.00225.00262.50337.50312.50412.50
Earnings Per Share-Unit Curr34.917.6216.9626.0736.5537.84
Earnings Per Share(Adj)-Unit Curr34.917.6216.9626.0736.5537.84
Book Value-Unit Curr257.64229.69224.17212.61195.24169.40